Stock Investments Feb 21 21

Stock Investments Feb 21 21

February 22, 2021

Stock Investments Feb 21 21:

Ticker

Company

Avg. Cost

Price (Feb.21.21)

Category

AMC

AMC

9.5017

5.70

Speculative

CHMA

Chiasma Inc.

4.26

4.20

Biotech

CLOV

Clover

14.62

10.98

Chamath

CLOVW

Clover Warrants

3.45

3.24

Chamath

DM

Desktop Metal

18.9737

26.09

Chamath/climate

DMTK

Dermtech

45.50

79.76

Biotech

GME

Gamestop

97.60

40.59

Speculative

IPOE.UN

SoFi

20.50

24.92

Chamath

KALA

Kala Pharma

9.23

9.02

Biotech

MILE

Metromile

16.99

19.30

Chamath

MP

MP Materials

15.73

45.05

Chamath

MP.WS

MP Warrants

4.60

31.84

Chamath

MWK

Mohawk

24.20

43.45

10x?

ONCT

Oncternal Therapeutics

5.9353

7.48

Biotech

OPEN

Open Door

27.25

31.58

Chamath

OPENW

Open Door Warrants

13.25

19.11

Chamath

PAVM

PavMed

4.35

5.55

Biotech

SE

Sea Limited

171.079

280

Long term 20% yoy

SFTBY

Softbank Group

41.3528

49.42

Long term 20% yoy

SKLZ

Skillz

20.92

35.94

10x?

SKLZ.WS

Skillz Warrants

8.10

24.37

10x?

SPCE

Virgin Galactic

20.1902

51.19

Chamath

SQ

Square

187.7289

276.57

Long term 20%

TBT

Proshares Trust

19.29

19.70

Inflation hedge

TDOC

Teladoc

229.9257

292.51

Long term 20%

TRIL

Trillium Therapeutics

12.9673

13.42

Biotech

Disclosure: All opinions are my own and don’t reflect anyone else. None of this is personal financial advice. Do your own due diligence before investing. This is what my portfolio consists of today but this will change over the next few years. Only invest what you’re comfortable with


Wanted to write this as a way to hold myself accountable. I only started investing and getting really interested in the market during last summer when I had a lot of time. Previously I had read 10+ books on personal finance and investing, but never put my own money into the market.


Right now, everything seems too high. I think a monkey throwing a dart at stocks would probably be making money in this market, especially because of how much the fed has pumped in.


However, I wanted to benchmark against myself over the next several decades to see how much my portfolio has evolved and my thinking has evolved. I believe the next decade will be largely negative across most equities indexes, but this could be a huge opportunity for stock pickers. Those who understand the future and bet on people who know what they’re talking about.


Below is the short form version of why I’ve invested in what I have.


Let’s see what happens. This is gonna be fun.


AMC:

-Specualtive against hedge funds. Interesting stuff going on with gamestop could happen with AMC. Not long term hold

CHMA:

-Derisked biotech asset with approval. Oral pills instead of daily injections. Approved asset that could provide 500M+ in revenue, could be a potential buyout candidate. Lot of ppl on Twitter like it (Danny biopharma).

CLOV & CLOVW

-Value based care shift. Chamath led SPAC. Short report came out and although investors didn’t disclose, I think this could still be a long term winner. Encaptured such small percentage of market

DM:

-Chamath led PIPE. Doing 3D printing. Awesome funds. Not just small scale but manufacturing scale 3D printing. Market expected to grow 150% YoY in next decade

DMTK:

-Patch for diagnosing skin cancer. Insurers coming on board. No biopsy needed. Could be 5-10x in next few years

GME:

-Purely speculative and reddit play

IPOE.UN:

-Chamath led SPAC. Solid founder and good team. Good investors. Democratizing finance. Also backend for a lot of fintech apps and should only grow going forward

KALA:

-Biotech buy. Eysuvius used in dry eye. Amazing patient feedback. Just got approved. Super cheap considering could be a billion dollar a year drug. Could get bought out for 4-5x near term.

MILE:

-Insurance. Strong founder, multiple unicorns, Chamath SPAC with other good investors.

MP/MP.WS:

-Supply chain in western world for all rare earth metals. Mostly done in China today. National security issue for US. Needed for manufacturing, especially with the electrification of the economy.

MWK:

-Third party seller on Amazon. Jonah Lupton recommended. Ecommerce play. AI back engine. Lot of insider holdings and not selling. Could grow to 10x in 10 years.

ONCT:

-Strongest bio conviction. ROR1 antibody, better than merck/velos bio (bought for 2.7B), this is trading at few hundred million mkt cap. Could 5-10x near term

OPEN & OPEN.WS:

-Real estate disruption. Digitization of real estate using AI. Lot of solid backers. Compete with Zillow/Redfin. Such small percentage of market today, huge room to grow

PAVM:

-Have multiple med device products that are approved. Esoguard/esocheck are better way to diagnose esophageal cancer than biopsy. More insurers could come online. Long-term hold. Could 10x in 5 years. Could be similar to exact sciences.

SE:

-Asian Amazon. Strong founder. Dominating E-sports in Asia, as well as payments. Moving into Brazil. This is a long term 20% yoy hold.

SFTBY:

-Strongest conviction to grow 20% yoy. Venture model deployed at scale around world. Able to invest in Asia as they grow in next few years, as well as high growth US tech. Should have some pullback soon but masahiro son also buying back more shares because of potential in next few years to explode. Trading at discount to intrinsic value of holdings. Bad press because of Wework but their holdings are all of the top tech firms around the world.

SKLZ & SKLZ.WS:

-Mobile gaming play. Have partnership with NFL recently announced. Mobile gaming exploding. Good developer pay and people can bet on it. Gambling play as well. 10x in 10 years type play.

SPCE:

-Virgin Galactic. Only space holding. Space going to explode in next decade. More than just commercial travel to space but also potential to bring back concord type plane so could democratize travel and be huge opportunity. Long term play but high valuation now, should see some pullback.

SQ:

-Own cash app. 20% yoy long term hold. Digital wallet/digital bank. Low fees. Strong founder. Leading incumbents to banks. CAC is insanely lower compared to banks. Unbanked market is massive.

TBT:

-Hedge against inflation. If US inflation goes nuts and rates go up, this could explode. May buy options on it at some point in future. Was trading 285 during great financial crisis in 08 so could run if more volatility and market turns. Will put 10% of portfolio into this and silver/gold as hedge.

TDOC:

-Telehealth and remote monitoring. Covid accelerated switch to telehealth. Acquiring lots of companies and only small portion of market today. Could be 10x in 10 years but long term hold.

TRIL:

-CD47 antibody that could be huge in solid tumors. Competitor acquired by Gilead for 4.7B and they’re at ~1.5B. News should release soon. Cleaner, less side effects, good efficacy. Buyout candidate. Lot of biotwitter people like it.

 

Other companies want to get into:

TMDX: transporting organs. Massive market. Great technology. Validated. Just starting to sell now. 10x in 10 years potential

GTHX (G1 Therapeutics): Danny biopharm loves it. 5x potential from here. Approved product in cancer. Cleaner/safer with chemo.

DIS: Disney I think could be a 20% yoy growth stock, given value of IP and Disney plus. Own so many franchises, continuing to grow Pixar. Global recognizable brand. Revenue from parks, cruises should recover quickly. Would put into long term holdings once more liquidity

Let's see how this next year plays out. Should be fascinating to watch.

Disclosure: this is not investment advice. This does not mean I will be investing in this companies forever as my portfolio may change dramatically over the course of my life. This is simply what my portfolio looks like on Feb 21.21.

Edit (Mar.28.2021): Mind changed because of current market conditions.

Anish display picture

Anish Kaushal

Hey there. I'm an Indo-British Canadian doctor turned healthcare venture capitalist. I read, write and obsess over sports in my spare time. Lover of Reggaeton music, podcasts and Oreo Mcflurries.
Twitter iconFacebook iconInstagram iconGoodreads iconEmail icon

Stock Investments Feb 21 21

Copy Share Link
Feb 22, 2021
Summary of my equities portfolio as of Feb 21.21.

Stock Investments Feb 21 21:

Ticker

Company

Avg. Cost

Price (Feb.21.21)

Category

AMC

AMC

9.5017

5.70

Speculative

CHMA

Chiasma Inc.

4.26

4.20

Biotech

CLOV

Clover

14.62

10.98

Chamath

CLOVW

Clover Warrants

3.45

3.24

Chamath

DM

Desktop Metal

18.9737

26.09

Chamath/climate

DMTK

Dermtech

45.50

79.76

Biotech

GME

Gamestop

97.60

40.59

Speculative

IPOE.UN

SoFi

20.50

24.92

Chamath

KALA

Kala Pharma

9.23

9.02

Biotech

MILE

Metromile

16.99

19.30

Chamath

MP

MP Materials

15.73

45.05

Chamath

MP.WS

MP Warrants

4.60

31.84

Chamath

MWK

Mohawk

24.20

43.45

10x?

ONCT

Oncternal Therapeutics

5.9353

7.48

Biotech

OPEN

Open Door

27.25

31.58

Chamath

OPENW

Open Door Warrants

13.25

19.11

Chamath

PAVM

PavMed

4.35

5.55

Biotech

SE

Sea Limited

171.079

280

Long term 20% yoy

SFTBY

Softbank Group

41.3528

49.42

Long term 20% yoy

SKLZ

Skillz

20.92

35.94

10x?

SKLZ.WS

Skillz Warrants

8.10

24.37

10x?

SPCE

Virgin Galactic

20.1902

51.19

Chamath

SQ

Square

187.7289

276.57

Long term 20%

TBT

Proshares Trust

19.29

19.70

Inflation hedge

TDOC

Teladoc

229.9257

292.51

Long term 20%

TRIL

Trillium Therapeutics

12.9673

13.42

Biotech

Disclosure: All opinions are my own and don’t reflect anyone else. None of this is personal financial advice. Do your own due diligence before investing. This is what my portfolio consists of today but this will change over the next few years. Only invest what you’re comfortable with


Wanted to write this as a way to hold myself accountable. I only started investing and getting really interested in the market during last summer when I had a lot of time. Previously I had read 10+ books on personal finance and investing, but never put my own money into the market.


Right now, everything seems too high. I think a monkey throwing a dart at stocks would probably be making money in this market, especially because of how much the fed has pumped in.


However, I wanted to benchmark against myself over the next several decades to see how much my portfolio has evolved and my thinking has evolved. I believe the next decade will be largely negative across most equities indexes, but this could be a huge opportunity for stock pickers. Those who understand the future and bet on people who know what they’re talking about.


Below is the short form version of why I’ve invested in what I have.


Let’s see what happens. This is gonna be fun.


AMC:

-Specualtive against hedge funds. Interesting stuff going on with gamestop could happen with AMC. Not long term hold

CHMA:

-Derisked biotech asset with approval. Oral pills instead of daily injections. Approved asset that could provide 500M+ in revenue, could be a potential buyout candidate. Lot of ppl on Twitter like it (Danny biopharma).

CLOV & CLOVW

-Value based care shift. Chamath led SPAC. Short report came out and although investors didn’t disclose, I think this could still be a long term winner. Encaptured such small percentage of market

DM:

-Chamath led PIPE. Doing 3D printing. Awesome funds. Not just small scale but manufacturing scale 3D printing. Market expected to grow 150% YoY in next decade

DMTK:

-Patch for diagnosing skin cancer. Insurers coming on board. No biopsy needed. Could be 5-10x in next few years

GME:

-Purely speculative and reddit play

IPOE.UN:

-Chamath led SPAC. Solid founder and good team. Good investors. Democratizing finance. Also backend for a lot of fintech apps and should only grow going forward

KALA:

-Biotech buy. Eysuvius used in dry eye. Amazing patient feedback. Just got approved. Super cheap considering could be a billion dollar a year drug. Could get bought out for 4-5x near term.

MILE:

-Insurance. Strong founder, multiple unicorns, Chamath SPAC with other good investors.

MP/MP.WS:

-Supply chain in western world for all rare earth metals. Mostly done in China today. National security issue for US. Needed for manufacturing, especially with the electrification of the economy.

MWK:

-Third party seller on Amazon. Jonah Lupton recommended. Ecommerce play. AI back engine. Lot of insider holdings and not selling. Could grow to 10x in 10 years.

ONCT:

-Strongest bio conviction. ROR1 antibody, better than merck/velos bio (bought for 2.7B), this is trading at few hundred million mkt cap. Could 5-10x near term

OPEN & OPEN.WS:

-Real estate disruption. Digitization of real estate using AI. Lot of solid backers. Compete with Zillow/Redfin. Such small percentage of market today, huge room to grow

PAVM:

-Have multiple med device products that are approved. Esoguard/esocheck are better way to diagnose esophageal cancer than biopsy. More insurers could come online. Long-term hold. Could 10x in 5 years. Could be similar to exact sciences.

SE:

-Asian Amazon. Strong founder. Dominating E-sports in Asia, as well as payments. Moving into Brazil. This is a long term 20% yoy hold.

SFTBY:

-Strongest conviction to grow 20% yoy. Venture model deployed at scale around world. Able to invest in Asia as they grow in next few years, as well as high growth US tech. Should have some pullback soon but masahiro son also buying back more shares because of potential in next few years to explode. Trading at discount to intrinsic value of holdings. Bad press because of Wework but their holdings are all of the top tech firms around the world.

SKLZ & SKLZ.WS:

-Mobile gaming play. Have partnership with NFL recently announced. Mobile gaming exploding. Good developer pay and people can bet on it. Gambling play as well. 10x in 10 years type play.

SPCE:

-Virgin Galactic. Only space holding. Space going to explode in next decade. More than just commercial travel to space but also potential to bring back concord type plane so could democratize travel and be huge opportunity. Long term play but high valuation now, should see some pullback.

SQ:

-Own cash app. 20% yoy long term hold. Digital wallet/digital bank. Low fees. Strong founder. Leading incumbents to banks. CAC is insanely lower compared to banks. Unbanked market is massive.

TBT:

-Hedge against inflation. If US inflation goes nuts and rates go up, this could explode. May buy options on it at some point in future. Was trading 285 during great financial crisis in 08 so could run if more volatility and market turns. Will put 10% of portfolio into this and silver/gold as hedge.

TDOC:

-Telehealth and remote monitoring. Covid accelerated switch to telehealth. Acquiring lots of companies and only small portion of market today. Could be 10x in 10 years but long term hold.

TRIL:

-CD47 antibody that could be huge in solid tumors. Competitor acquired by Gilead for 4.7B and they’re at ~1.5B. News should release soon. Cleaner, less side effects, good efficacy. Buyout candidate. Lot of biotwitter people like it.

 

Other companies want to get into:

TMDX: transporting organs. Massive market. Great technology. Validated. Just starting to sell now. 10x in 10 years potential

GTHX (G1 Therapeutics): Danny biopharm loves it. 5x potential from here. Approved product in cancer. Cleaner/safer with chemo.

DIS: Disney I think could be a 20% yoy growth stock, given value of IP and Disney plus. Own so many franchises, continuing to grow Pixar. Global recognizable brand. Revenue from parks, cruises should recover quickly. Would put into long term holdings once more liquidity

Let's see how this next year plays out. Should be fascinating to watch.

Disclosure: this is not investment advice. This does not mean I will be investing in this companies forever as my portfolio may change dramatically over the course of my life. This is simply what my portfolio looks like on Feb 21.21.

Edit (Mar.28.2021): Mind changed because of current market conditions.